MEREDITH MCMANAMAN: Open Payments
NPI 1740910397 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,487 in 93 payments from 14 companies in 2025. Trend: 2023 $1,752 · 2024 $1,390 · 2025 $1,487
Food & beverage: $1,487
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $483 |
| Novartis Pharmaceuticals Corporation | 18 | $293 |
| Lilly USA, LLC | 15 | $214 |
| GENZYME CORPORATION | 5 | $96 |
| UCB, Inc. | 4 | $88 |
| Amgen Inc. | 3 | $71 |
| Janssen Biotech, Inc. | 4 | $68 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
| Botanix SB Inc | 2 | $33 |
Products named: SKYRIZI, COSENTYX, TALTZ, RINVOQ, DUPIXENT, Bimzelx, OTEZLA, TREMFYA.
Industry payments across NE — which companies pay providers there.
